A detailed history of Enterprise Financial Services Corp transactions in Novo Nordisk A S stock. As of the latest transaction made, Enterprise Financial Services Corp holds 2,929 shares of NVO stock, worth $248,965. This represents 0.2% of its overall portfolio holdings.

Number of Shares
2,929
Previous 3,205 8.61%
Holding current value
$248,965
Previous $457,000 23.85%
% of portfolio
0.2%
Previous 0.28%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$119.07 - $145.42 $32,863 - $40,135
-276 Reduced 8.61%
2,929 $348,000
Q2 2024

Aug 13, 2024

BUY
$122.71 - $146.91 $613 - $734
5 Added 0.16%
3,205 $457,000
Q1 2024

May 14, 2024

SELL
$102.11 - $135.92 $27,161 - $36,154
-266 Reduced 7.67%
3,200 $410,000
Q4 2023

Feb 09, 2024

SELL
$87.78 - $105.45 $877 - $1,054
-10 Reduced 0.29%
3,466 $358,000
Q3 2023

Oct 31, 2023

BUY
$90.94 - $199.54 $162,146 - $355,779
1,783 Added 105.32%
3,476 $316,000
Q2 2023

Aug 11, 2023

BUY
$155.98 - $172.65 $3,431 - $3,798
22 Added 1.32%
1,693 $273,000
Q1 2023

May 15, 2023

SELL
$132.34 - $159.14 $23,027 - $27,690
-174 Reduced 9.43%
1,671 $265,000
Q4 2022

Feb 14, 2023

BUY
$102.55 - $135.33 $189,204 - $249,683
1,845 New
1,845 $249,000
Q2 2022

Aug 09, 2022

BUY
$103.24 - $121.81 $195,330 - $230,464
1,892 New
1,892 $211,000
Q4 2021

Feb 14, 2022

SELL
$95.88 - $117.08 $19,176 - $23,416
-200 Closed
0 $0
Q3 2021

Nov 15, 2021

SELL
$84.42 - $106.62 $61,964 - $78,259
-734 Reduced 78.59%
200 $19,000
Q2 2021

Aug 16, 2021

BUY
$67.66 - $84.76 $3,788 - $4,746
56 Added 6.38%
934 $78,000
Q1 2021

May 13, 2021

BUY
$67.06 - $75.82 $5,968 - $6,747
89 Added 11.28%
878 $59,000
Q4 2020

Feb 12, 2021

SELL
$63.89 - $73.8 $5,813 - $6,715
-91 Reduced 10.34%
789 $55,000
Q2 2020

Aug 04, 2020

BUY
$58.54 - $67.94 $995 - $1,154
17 Added 1.97%
880 $58,000
Q1 2020

May 15, 2020

BUY
$49.46 - $64.78 $741 - $971
15 Added 1.77%
863 $52,000
Q3 2019

Oct 31, 2019

BUY
$47.54 - $53.43 $4,896 - $5,503
103 Added 13.83%
848 $44,000
Q2 2019

Jul 30, 2019

SELL
$46.79 - $52.47 $3,368 - $3,777
-72 Reduced 8.81%
745 $38,000
Q1 2019

Apr 26, 2019

BUY
$46.36 - $52.63 $12,007 - $13,631
259 Added 46.42%
817 $42,000
Q4 2018

Jan 25, 2019

SELL
$41.54 - $47.25 $2,617 - $2,976
-63 Reduced 10.14%
558 $26,000
Q2 2018

Jul 27, 2018

SELL
$44.29 - $50.42 $4,074 - $4,638
-92 Reduced 12.9%
621 $29,000
Q1 2018

Apr 27, 2018

BUY
$48.49 - $58.14 $9,358 - $11,221
193 Added 37.12%
713 $35,000
Q3 2017

Oct 27, 2017

BUY
$41.15 - $49.22 $21,398 - $25,594
520
520 $25,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $192B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Enterprise Financial Services Corp Portfolio

Follow Enterprise Financial Services Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Enterprise Financial Services Corp, based on Form 13F filings with the SEC.

News

Stay updated on Enterprise Financial Services Corp with notifications on news.